NovaBridge Biosciences Depreciation & Amortization Growth & History (NBP)

NovaBridge Biosciences's depreciation and amortization was $68,000 for fiscal 2025.

View full NovaBridge Biosciences company overview

NovaBridge Biosciences annual depreciation and amortization history

NovaBridge Biosciences annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$68,000−$232,000−77.33%
20242024-12-31$300,000−$200,000−40.00%
20232023-12-31$500,000$300,000+150.00%
20222022-12-31$200,000−$2.1M−91.24%
20212021-12-31$2.3M$93,000+4.24%
20202020-12-31$2.2M$779,000+55.17%
20192019-12-31$1.4M

NovaBridge Biosciences depreciation and amortization trends

Over the last five fiscal years, NovaBridge Biosciences's depreciation and amortization decreased from $2.2M to $68,000, a change of −$2.1M. The latest reported quarter, Q4 2025, shows $216,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review NovaBridge Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about NBP yet. Start the conversation.

Write the first post